Solventum Balance Sheet
SOLV / Health Care|4 years of annual SEC 10-K data (FY2022-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
Solventum had $14.3B in total assets and $5.0B in shareholders' equity as of FY2025. Total debt was $5.0B against $878M in cash, resulting in $4.2B net debt.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash & Equivalents | $878.0M | $762.0M | $194.0M | - |
| Accounts Receivable | $1.0B | $1.0B | $1.3B | - |
| Inventory | $1.1B | $965.0M | $857.0M | - |
| Current Assets | $3.9B | $3.2B | $2.5B | - |
| PP&E (Net) | $1.3B | $1.6B | $1.5B | - |
| Goodwill | $5.7B | $6.4B | $6.5B | $6.4B |
| Total Assets | $14.3B | $14.5B | $13.9B | - |
| Current Liabilities | $3.1B | $2.7B | $1.7B | - |
| Total Debt | $5.0B | $8.0B | $0 | - |
| Shareholders' Equity | $5.0B | $3.0B | $11.7B | $11.7B |